These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 29281850)

  • 41. Recombinant vaccinia virus-induced T-cell immunity: quantitation of the response to the virus vector and the foreign epitope.
    Harrington LE; Most Rv Rv; Whitton JL; Ahmed R
    J Virol; 2002 Apr; 76(7):3329-37. PubMed ID: 11884558
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
    Sorensen MR; Holst PJ; Pircher H; Christensen JP; Thomsen AR
    Eur J Immunol; 2009 Oct; 39(10):2725-36. PubMed ID: 19637230
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vaccinia Virus Vectors Targeting Peptides for MHC Class II Presentation to CD4
    Hobbs SJ; Harbour JC; Yates PA; Ortiz D; Landfear SM; Nolz JC
    Immunohorizons; 2020 Jan; 4(1):1-13. PubMed ID: 31896555
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Qualitative differences in cellular immunogenicity elicited by hepatitis C virus T-Cell vaccines employing prime-boost regimens.
    Tan WG; Zubkova I; Kachko A; Wells F; Adler H; Sutter G; Major ME
    PLoS One; 2017; 12(7):e0181578. PubMed ID: 28732046
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prime-boost immunization schedules based on influenza virus and vaccinia virus vectors potentiate cellular immune responses against human immunodeficiency virus Env protein systemically and in the genitorectal draining lymph nodes.
    Gherardi MM; Nájera JL; Pérez-Jiménez E; Guerra S; García-Sastre A; Esteban M
    J Virol; 2003 Jun; 77(12):7048-57. PubMed ID: 12768024
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differential kinetics of antigen dependency of CD4+ and CD8+ T cells.
    Rabenstein H; Behrendt AC; Ellwart JW; Naumann R; Horsch M; Beckers J; Obst R
    J Immunol; 2014 Apr; 192(8):3507-17. PubMed ID: 24639353
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antigen-specific tumor vaccine efficacy in vivo against prostate cancer with low class I MHC requires competent class II MHC.
    Neeley YC; McDonagh KT; Overwijk WW; Restifo NP; Sanda MG
    Prostate; 2002 Nov; 53(3):183-91. PubMed ID: 12386918
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Virus-encoded ectopic CD74 enhances poxvirus vaccine efficacy.
    Walline CC; Deffit SN; Wang N; Guindon LM; Crotzer VL; Liu J; Hollister K; Eisenlohr LC; Brutkiewicz RR; Kaplan MH; Blum JS
    Immunology; 2014 Apr; 141(4):531-9. PubMed ID: 24205828
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dendritic cells are preferentially targeted among hematolymphocytes by Modified Vaccinia Virus Ankara and play a key role in the induction of virus-specific T cell responses in vivo.
    Liu L; Chavan R; Feinberg MB
    BMC Immunol; 2008 Apr; 9():15. PubMed ID: 18412969
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CD4+ Th-APC with acquired peptide/MHC class I and II complexes stimulate type 1 helper CD4+ and central memory CD8+ T cell responses.
    Umeshappa CS; Huang H; Xie Y; Wei Y; Mulligan SJ; Deng Y; Xiang J
    J Immunol; 2009 Jan; 182(1):193-206. PubMed ID: 19109150
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Viral-vectored boosting of OmcB- or CPAF-specific T-cell responses fail to enhance protection from Chlamydia muridarum in infection-immune mice and elicits a non-protective CD8-dominant response in naïve mice.
    Poston TB; Girardi J; Polson AG; Bhardwaj A; Yount KS; Jaras Salas I; Trim LK; Li Y; O'Connell CM; Leahy D; Harris JM; Beagley KW; Goonetilleke N; Darville T
    Mucosal Immunol; 2024 Oct; 17(5):1005-1018. PubMed ID: 38969067
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Myristoylation increases the CD8+T-cell response to a GFP prototype antigen delivered by modified vaccinia virus Ankara.
    Marr L; Lülf AT; Freudenstein A; Sutter G; Volz A
    J Gen Virol; 2016 Apr; 97(4):934-940. PubMed ID: 26864442
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Virus-specific MHC-class II-restricted TCR-transgenic mice: effects on humoral and cellular immune responses after viral infection.
    Oxenius A; Bachmann MF; Zinkernagel RM; Hengartner H
    Eur J Immunol; 1998 Jan; 28(1):390-400. PubMed ID: 9485218
    [TBL] [Abstract][Full Text] [Related]  

  • 54. E3L and F1L Gene Functions Modulate the Protective Capacity of Modified Vaccinia Virus Ankara Immunization in Murine Model of Human Smallpox.
    Volz A; Jany S; Freudenstein A; Lantermann M; Ludwig H; Sutter G
    Viruses; 2018 Jan; 10(1):. PubMed ID: 29300297
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epithelial and dendritic cells in the thymic medulla promote CD4+Foxp3+ regulatory T cell development via the CD27-CD70 pathway.
    Coquet JM; Ribot JC; Bąbała N; Middendorp S; van der Horst G; Xiao Y; Neves JF; Fonseca-Pereira D; Jacobs H; Pennington DJ; Silva-Santos B; Borst J
    J Exp Med; 2013 Apr; 210(4):715-28. PubMed ID: 23547099
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The CD4⁺ T-cell help signal is transmitted from APC to CD8⁺ T-cells via CD27-CD70 interactions.
    Feau S; Garcia Z; Arens R; Yagita H; Borst J; Schoenberger SP
    Nat Commun; 2012 Jul; 3():948. PubMed ID: 22781761
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dendritic cells from mice neonatally vaccinated with modified vaccinia virus Ankara transfer resistance against herpes simplex virus type I to naive one-week-old mice.
    Franchini M; Hefti H; Vollstedt S; Glanzmann B; Riesen M; Ackermann M; Chaplin P; Shortman K; Suter M
    J Immunol; 2004 May; 172(10):6304-12. PubMed ID: 15128820
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CD4+ T cell help is dispensable for protective CD8+ T cell memory against mousepox virus following vaccinia virus immunization.
    Fang M; Remakus S; Roscoe F; Ma X; Sigal LJ
    J Virol; 2015 Jan; 89(1):776-83. PubMed ID: 25355885
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma.
    Abaitua F; Rodríguez JR; Garzón A; Rodríguez D; Esteban M
    Virus Res; 2006 Mar; 116(1-2):11-20. PubMed ID: 16214252
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Active CD4+ helper T cells directly stimulate CD8+ cytotoxic T lymphocyte responses in wild-type and MHC II gene knockout C57BL/6 mice and transgenic RIP-mOVA mice expressing islet beta-cell ovalbumin antigen leading to diabetes.
    Ye Z; Ahmed KA; Hao S; Zhang X; Xie Y; Munegowda MA; Meng Q; Chibbar R; Xiang J
    Autoimmunity; 2008 Nov; 41(7):501-11. PubMed ID: 18855194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.